Jones Financial Companies Lllp Abb Vie Inc. Transaction History

Jones Financial Companies Lllp

$97.4 Billion
Q3 2024

A detailed history of Jones Financial Companies Lllp transactions in Abb Vie Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 104,932 shares of ABBV stock, worth $18.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

104,932

Previous 63,027 66.49%

Holding current value

$18.9 Million

Previous $10.8 Million 91.68%

% of portfolio

0.02%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $6.87 Million - $8.35 Million	41,905 Added 66.49%	104,932 $20.7 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $4.13 Million - $4.82 Million	26,690 Added 73.45%	63,027 $10.8 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $725,263 - $826,369	4,538 Added 14.27%	36,337 $6.62 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $326,524 - $367,743	2,373 Added 8.06%	31,799 $4.93 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $1.2 Million - $1.39 Million	-8,975 Reduced 23.37%	29,426 $4.39 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $3.6 Million - $4.48 Million	27,159 Added 241.59%	38,401 $5.17 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $52,927 - $60,953	-366 Reduced 3.15%	11,242 $1.79 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $146,055 - $175,158	1,056 Added 10.01%	11,608 $1.88 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $130,854 - $150,081	-975 Reduced 8.46%	10,552 $1.42 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $2,614 - $3,324	19 Added 0.17%	11,527 $1.77 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $20,720 - $25,708	-157 Reduced 1.35%	11,508 $1.87 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $37,600 - $47,575	-350 Reduced 2.91%	11,665 $1.58 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $24,897 - $28,262	-234 Reduced 1.91%	12,015 $1.3 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $280,279 - $312,247	-2,664 Reduced 17.86%	12,249 $1.38 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $91,865 - $101,132	898 Added 6.41%	14,913 $1.61 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $24,871 - $33,579	309 Added 2.25%	14,015 $1.5 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $443,553 - $520,585	-5,163 Reduced 27.36%	13,706 $1.2 Million
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $154,150 - $206,276	-2,101 Reduced 10.02%	18,869 $1.85 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $262,515 - $398,005	4,070 Added 24.08%	20,970 $1.6 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $61,238 - $76,622	849 Added 5.29%	16,900 $1.5 Million
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $9,887 - $11,888	-157 Reduced 0.97%	16,051 $1.22 Million
Q2 2019 Aug 02, 2019	SELL	$65.7 - $83.98 $16,490 - $21,078	-251 Reduced 1.53%	16,208 $1.18 Million
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $209,203 - $246,222	-2,712 Reduced 14.15%	16,459 $1.33 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $136,393 - $168,209	-1,752 Reduced 8.37%	19,171 $1.77 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $193,290 - $214,878	-2,174 Reduced 9.41%	20,923 $1.98 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $1,436 - $1,699	-16 Reduced 0.07%	23,097 $2.14 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $712,525 - $954,138	-7,744 Reduced 25.1%	23,113 $2.19 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $203,211 - $222,838	-2,269 Reduced 6.85%	30,857 $2.98 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $616,635 - $787,634	-8,828 Reduced 21.04%	33,126 $2.94 Million
Q2 2017 Aug 14, 2017	BUY	N/A	41,954	41,954 $3.04 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.

Account

Jones Financial Companies Lllp Abb Vie Inc. Transaction History